Allogeneic hematopoietic SCT (HCT) offers potentially curative therapy for patients with hematologic malignancies, but also carries significant risks. Assessing potential risk versus benefit is a ...
CHARLOTTESVILLE, Va., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that ...
The European Respiratory Society (ERS) and American Thoracic Society (ATS) just updated their standards for interpreting lung function testing. The last joint society update from these organizations ...
The diffusion capacity of the lung for carbon monoxide (DLCO) is used to measure the body's ability to transfer oxygen across the alveolar-capillary membrane. [1] Internists use this test to identify ...
A 2% decline in FVC or DLco significantly increases the risk of death or lung transplant in IPF patients, challenging current clinical thresholds. The study suggests that smaller declines in lung ...
Please provide your email address to receive an email when new articles are posted on . All-cause mortality in COPD patients was “strongly predicted” by diffusing capacity of the lung for carbon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback